ZHEJIANG ANGLIKANG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.97 CNY | +0.38% |
|
+10.44% | -26.44% |
| Sales 2021 | 1.38B 191M 260M | Sales 2022 | 1.57B 217M 296M | Capitalization | 3.68B 509M 695M |
|---|---|---|---|---|---|
| Net income 2021 | 120M 16.57M 22.64M | Net income 2022 | 127M 17.54M 23.96M | EV / Sales 2021 | 1.98 x |
| Net cash position 2021 | 747M 103M 141M | Net cash position 2022 | 458M 63.22M 86.36M | EV / Sales 2022 | 2.06 x |
| P/E ratio 2021 |
28.6
x | P/E ratio 2022 |
29.1
x | Employees | 981 |
| Yield 2021 |
0.83% | Yield 2022 |
1.11% | Free-Float | 50.28% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.38% | ||
| 1 week | +10.44% | ||
| Current month | +0.82% | ||
| 1 month | +1.08% | ||
| 3 months | -10.63% | ||
| 6 months | -15.46% | ||
| Current year | -26.44% |
1 week
14.88
16.17
1 month
13.8916.70
Current year
11.8422.04
1 year
11.8422.59
3 years
11.8425.79
5 years
11.8433.19
10 years
11.8433.19
| Managers | Title | Age | Since |
|---|---|---|---|
Song Ying Mao
DFI | Director of Finance/CFO | 46 | 21-01-04 |
Nan Ping Fang
CHM | Chairman | 57 | 14-12-08 |
Lin Li Zhao
BRD | Director/Board Member | 41 | 21-01-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiu Fang Zhao
BRD | Director/Board Member | 55 | 21-01-04 |
Nan Ping Fang
CHM | Chairman | 57 | 14-12-08 |
Hui Hao Lu
BRD | Director/Board Member | 54 | 14-12-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 15.97 | +0.38% | 1,627,337 |
| 24-04-25 | 15.91 | +1.53% | 1,497,317 |
| 24-04-24 | 15.67 | +2.49% | 1,597,445 |
| 24-04-23 | 15.29 | +2.55% | 1,540,422 |
| 24-04-22 | 14.91 | +3.11% | 1,865,933 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a China-based company principally engaged in the research, development, production and sales of chemical raw materials and preparations. The Company's products mainly include cephalosporin and penicillin series, anti-hypertension series, digestive system series, kidney disease series and others.
Sector
Pharmaceuticals
Calendar
2024-05-15
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -26.44% | 435M | |
| +25.83% | 661B | |
| +26.86% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.87% | 231B | |
| +5.27% | 200B | |
| -8.88% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002940 Stock
